NOXXON Pharma is a clinical-stage biopharmaceutical company whose core focus is on improving cancer treatment by targeting the tumor microenvironment. NOXXON’s goal is to significantly enhance the effectiveness of cancer treatments including immuno-oncology approaches (such as immune checkpoint inhibitors) and current standards of care (such as chemotherapy and radiotherapy). NOXXON's Spiegelmer® platform has generated a proprietary pipeline of clinical-stage assets including its lead cancer candidate NOX-A12, which is the subject of a clinical immuno-oncology collaboration agreement with Merck & Co. / MSD (NYSE: MRK) to study NOX-A12 combined with KEYTRUDA® (pembrolizumab) in pancreatic and colorectal cancer. NOXXON’s pipeline also contains NOX-E36, which targets other tumor microenvironment targets implicated in cancer spread and immune privilege of tumors.
View Top Employees from NOXXON Pharma AGWebsite | http://www.noxxon.com |
Ticker | EPA:ALNOX |
Revenue | $8 million |
Funding | $64.1 million |
Employees | 17 (15 on RocketReach) |
Founded | 1998 |
Address | Max-Dohrn-Strasse 8-10, Berlin, Berlin 10589, DE |
Phone | +49 30 7262470 |
Fax | +49 30 726247225 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Drug Manufacturing & Research, Health Care, Pharmaceutical |
Web Rank | 15 Million |
Keywords | Noxxon Berlin, Pharm "Financing Agreement" "Annual Report", Novabay Pharmaceuticals, Noxxon Pharma |
Competitors | Cancer Prevention Pharmaceuticals, Inc, Leap Therapeutics, Lumos Pharma, Marina Biotech, Inc., OxThera |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular NOXXON Pharma AG employee's phone or email?
The NOXXON Pharma AG annual revenue was $8 million in 2023.
Bryan Jennings is the CFO of NOXXON Pharma AG.
15 people are employed at NOXXON Pharma AG.
NOXXON Pharma AG is based in Berlin, Berlin.
The NAICS codes for NOXXON Pharma AG are [32, 32541, 3254, 325].
The SIC codes for NOXXON Pharma AG are [283, 28].